Concepedia

Sho Isoyama

SI

5

Publications

156

Citations

5

H-Index

2012

Active since

Affiliations

Japanese Foundation For Cancer Research(Current)

Zenyaku Kogyo (Japan)

National Cancer Center Hospital East

Sho Isoyama is an author at Japanese Foundation For Cancer Research specializing in tumor biology, cancer research, and cancer biology.

ORCID

Top concepts

Publications per year

2012–2025

5

Publications

5

Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama et al. · Journal for ImmunoTherapy of Cancer · 2021 · 80 citations · Full text

A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation

Xin Peng, Xin Huang, Talal Ben Lulu et al. · Molecular Cancer · 2024 · 28 citations · Full text

Establishment of phosphatidylinositol 3‐kinase inhibitor‐resistant cancer cell lines and therapeutic strategies for overcoming the resistance

Sho Isoyama, Shingo Dan, Yumiko Nishimura et al. · Cancer Science · 2012 · 18 citations · Full text

SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis

Akane Ogawa, Keiichi Izumikawa, Sota Tate et al. · Molecular Cell · 2025 · 18 citations · Full text

Basal expression of insulin‐like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3‐kinase inhibitor ZSTK474

Sho Isoyama, Gensei Kajiwara, Naomi Tamaki et al. · Cancer Science · 2014 · 12 citations · Full text

, , +16

Rows per page

1–5 of 5